GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Country] SE/NO/DK — Norway is the outlier and not in a good way — 25 comments in the full submission. View in context.
530
c/glp1eu·submitted 10 days ago by u/dario_petrescu

[Country] SE/NO/DK — Norway is the outlier and not in a good way

Countrybranch of 6 comments

SE/NO/DK — Norway is the outlier and not in a good way. It is the sort of thing everyone half-believes and nobody writes down. Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content. Pack sizes and…

Read the full submission and all 25 comments →

This branch

6 comments, started 9 days ago
u/cato_batista10 points·9 days ago

the reimbursement criteria are published in most member states

replysharereportpermalink
u/spain_receta3 points·9 days ago

Have you read the published reimbursement criteria where you are?

replysharereportpermalink
u/honest_syringe_maybe1 point·8 days ago

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
u/dose_diary_danalog keeper1 point·8 days ago

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/cesar_oyelaran4 points·9 days ago

Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.

replysharereportpermalink
u/dario_petrescuOP3 points·8 days ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.